Inhibition of cytochrome P450 3A enzyme by Millettia aboensis: its effect on the pharmacokinetic properties of efavirenz and nevirapine

Nduka, Sunday O.; Okonta, Mathew J.; Ajaghaku, Daniel L.; Amorha, Kosisochi C.; Ukwe, Chinwe V..
Rev. bras. farmacogn ; 27(2): 228-235, Mar.-Apr. 2017. tab, graf
Artículo en Inglés | LILACS | ID: biblio-843803

Documentos relacionados

  1. Preclinical Pharmacokinetics and Bioavailability of Oxypeucedanin in Rats after Single Intravenous and Oral Administration.
  2. Effects of vitamin C on the pharmacokinetics and pharmacodynamics of nimodipine in rats.
  3. Analysis of 3-nitropropionic acid in Fabaceae plants by HPLC-MS/MS.
  4. Metabolites identification and pharmacokinetic profile of hirsuteine, a bioactive component in Uncaria in rats by ultra-high performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
  5. [Pharmacokinetics of active ingredients of Pudilan Xiaoyan Oral Liquid in rats and effect on liver drug-metabolizing enzymes].
  6. In Vitro and In Vivo Metabolic Activation of Obacunone, A Bioactive and Potentially Hepatotoxic Constituent of Dictamni Cortex.
  7. Protective effects of Dialium guineense pulp on aspirin-induced gastric mucosal injury in albino rats.
  8. Lack of pharmacokinetic interaction between derazantinib and naringin in rats.
  9. Evaluation of non-clinical toxicity of extract and vouacapans from fruits of <i>Pterodon pubescens</i> Benth.
  10. In vivo inhibitory effects of puerarin on selected rat cytochrome P450 isoenzymes.